CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $120,165,474
- in 11 filings, $3.7M under 10b5-1 plans
Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-27 | Bergstrom Donald A President, R&D | Sale | −999 | $20.31 | $20K | 91,494 |
| 2022-06-24 | Bergstrom Donald A President, R&D | Option exercise | +8,000 | $4.12 | $33K | 100,493 |
| 2022-06-24 | Bergstrom Donald A President, R&D | Sale | −8,000 | $20.00 | $160K | 92,493 |
| 2022-06-24 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −8,000 | 178,456 | ||
| 2022-05-27 | Murcko Mark Director | Grant or award · Stock Option (Right to Buy) | +41,597 | 41,597 | ||
| 2022-05-27 | INGRAM DOUGLAS S Director | Grant or award · Stock Option (Right to Buy) | +41,597 | 41,597 | ||
| 2022-05-27 | HILL LINDA A Director | Grant or award · Stock Option (Right to Buy) | +41,597 | 41,597 | ||
| 2022-05-27 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +41,597 | 41,597 | ||
| 2022-05-27 | Shawver Laura Director | Grant or award · Stock Option (Right to Buy) | +41,597 | 41,597 | ||
| 2022-05-27 | Rubin Jami Director | Grant or award · Stock Option (Right to Buy) | +41,597 | 41,597 | ||
| 2022-05-02 | Bergstrom Donald A President, R&D | Option exercise | +13,000 | $4.12 | $54K | 105,493 |
| 2022-05-02 | Bergstrom Donald A President, R&D | Sale | −13,000 | $24.62 | $320K | 92,493 |
| 2022-05-02 | Bergstrom Donald A President, R&D | Option exercise · Stock Option (Right to Buy) | −13,000 | 186,456 | ||
| 2022-04-28 | Bergstrom Donald A President, R&D | Sale | −1,811 | $25.57 | $46K | 92,493 |
| 2022-04-28 | Porter Andy Chief Administrative Officer | Sale | −435 | $25.57 | $11K | 46,588 |
| 2022-04-28 | Catinazzo Thomas Chief Financial Officer | Sale | −725 | $25.57 | $19K | 53,252 |
| 2022-04-28 | Adams Brian Chief Legal Officer | Sale | −708 | $25.57 | $18K | 63,876 |
| 2022-04-14 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $4.12 | $58K | 267,740 |
| 2022-04-14 | Patel Sanjiv President and CEO | Sale | −14,000 | $30.51 | $427K | 253,740 |
| 2022-04-14 | Patel Sanjiv President and CEO | Option exercise | +14,000 | $5.04 | $71K | 267,740 |
Page 19 of 27 · 534 trades